Can special cookies fight inflammation? new study tests the idea
NCT ID NCT04190706
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study tested whether eating fortified biscuits and cookies daily for nine weeks could lower inflammation in 62 adults with abdominal obesity and cardiometabolic risk. Participants ate either fortified or standard biscuits and cookies, and researchers measured inflammatory markers in the blood. The goal was to see if these functional foods could help prevent heart disease and diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC RISK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre de Recherche en Nutrition Humaine Rhône-Alpes
Pierre-Bénite, 69310, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fortified biscuits and cookies containing fibres, polyphenols, omega-3, and slow digestible starch
What this could lead to
If it works, this could point toward a simple dietary approach to lower inflammation and reduce cardiometabolic risk.
What could go wrong
This is a small, early-stage trial with only 62 participants, and the effects may not be large or long-lasting. Dietary interventions often show modest results.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.